Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480891 · ClinicalTrials.gov registry record
Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
A clinical trial, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- 3
- Enrollment target
NCT05480891: Clinical Trial study, sponsored by University of Illinois at Chicago.
NCT05480891 is a clinical trial that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05480891 was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This research study is being done for 2 reasons: 1) The investigators want to learn about the eating, smoking and drinking habits of adults, 18 years of age and older, in various Chicago communities, and 2) the investigators want to offer screening for participants whose smoking and drinking habits put them at risk for cancer.
Primary Outcome
The researchers will collect data on the consumption of alcohol and tobacco as they are known risk factors for ESCC. The researchers will specifically assess consumption of fortified wines and mentholated cigarettes based on the targeted marketing of these products in identified communities. The researchers will also assess consumption of fresh fruits and vegetables and proportion of fat in dietary consumption to assess whether these conditions are associated with cancer risk.
Interventions
- PROCEDURE Transnasal Esophagoscopy (TNE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-04-05 |
| Est. Completion | 2025-03-19 |
Why NCT05480891 stopped before completion
NCT05480891 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Transnasal Esophagoscopy (TNE) is the first listed.
NCT05480891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05480891 about?
NCT05480891 is a clinical study titled "Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening". This research study is being done for 2 reasons: 1) The investigators want to learn about the eating, smoking and drinking habits of adults, 18 years of age and older, in various Chicago communities, and 2) the investigators want to offer screening for participants whose smoking and drinking habits ...
What is the current status of trial NCT05480891?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2023-04-05. Estimated completion is 2025-03-19.
What interventions are being tested in trial NCT05480891?
The interventions under investigation include: Transnasal Esophagoscopy (TNE) (PROCEDURE).
Who is sponsoring clinical trial NCT05480891?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI